Uses, Dosage & Side Effects: Relyvrio Powder
Relyvrio Powder
| Generic name | sodium phenylbutyrate and taurursodiol |
|---|---|
| Drug class | Miscellaneous central nervous system agents |
| Forms | Powder for oral suspension, supplied in single-dose packets |
Relyvrio is a powder medicine that combines two active ingredients, sodium phenylbutyrate and taurursodiol, to treat amyotrophic lateral sclerosis (ALS) in adults. It was voluntarily removed from the U.S. and Canadian markets in April 2024 after disappointing results from a later clinical trial, but patients already using it could continue through a free drug program.
Read the full guideUses, dosage, side effects, precautions, and sources, written from the same verified facts.
General information, not medical advice
Your prescriber and the leaflet in your pack know your situation. This page does not.
- Follow your prescriber and the leaflet
- Don't start, stop, or change a dose on your own
- Doses and warnings differ by country and product
Took too much, or feel seriously unwell? Get urgent medical help now.
Facts checked by a personFull disclaimer
